MSCs from Amniotic Membrane

Placental amniotic-membrane MSCs are immunomodulatory, anti-inflammatory and paracrine-active mesenchymal cells — the most widely studied cell type in modern regenerative medicine.

How MSCs from Amniotic Membrane are used

The therapeutic value of MSCs from Amniotic Membrane lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where MSCs from Amniotic Membrane feature

Quality & safety

• GMP-certified preparation in the European Union
• Characterised, viability-tested cells from a certified bank
• Personalised dosing within a physician-led protocol
• Transparent pricing — €3,000–€8,000 per programme

Educational information. MSCs from Amniotic Membrane protocols for several conditions remain investigational; outcomes vary by patient.